The application and progression of CRISPR/Cas9 technology in ophthalmological diseases

被引:20
作者
Hu, Xumeng [1 ]
Zhang, Beibei [1 ]
Li, Xiaoli [1 ]
Li, Miao [1 ]
Wang, Yange [1 ]
Dan, Handong [1 ]
Zhou, Jiamu [1 ]
Wei, Yuanmeng [1 ]
Ge, Keke [1 ]
Li, Pan [1 ]
Song, Zongming [1 ]
机构
[1] Zhengzhou Univ, Henan Prov Peoples Hosp, Peoples Hosp, Henan Eye Hosp,Henan Eye Inst, Zhengzhou 450003, Henan, Peoples R China
关键词
LEBER CONGENITAL AMAUROSIS; RETINAL GENE-THERAPY; MACULAR DEGENERATION; RETINITIS-PIGMENTOSA; MUTATIONS; REPEATS; RNA; DNA; IDENTIFICATION; DYSTROPHY;
D O I
10.1038/s41433-022-02169-1
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated nuclease (Cas) system is an adaptive immune defence system that has gradually evolved in bacteria and archaea to combat invading viruses and exogenous DNA. Advances in technology have enabled researchers to enhance their understanding of the immune process in vivo and its potential for use in genome editing. Thus far, applications of CRISPR/Cas9 genome editing technology in ophthalmology have included gene therapy for corneal dystrophy, glaucoma, congenital cataract, Leber's congenital amaurosis, retinitis pigmentosa, Usher syndrome, fundus neovascular disease, proliferative vitreoretinopathy, retinoblastoma and other eye diseases. Additionally, the combination of CRISPR/Cas9 genome editing technology with adeno-associated virus vector and inducible pluripotent stem cells provides further therapeutic avenues for the treatment of eye diseases. Nonetheless, many challenges remain in the development of clinically feasible retinal genome editing therapy. This review discusses the development, as well as mechanism of CRISPR/Cas9 and its applications and challenges in gene therapy for eye diseases.
引用
收藏
页码:607 / 617
页数:11
相关论文
共 111 条
[1]   Search-and-replace genome editing without double-strand breaks or donor DNA [J].
Anzalone, Andrew V. ;
Randolph, Peyton B. ;
Davis, Jessie R. ;
Sousa, Alexander A. ;
Koblan, Luke W. ;
Levy, Jonathan M. ;
Chen, Peter J. ;
Wilson, Christopher ;
Newby, Gregory A. ;
Raguram, Aditya ;
Liu, David R. .
NATURE, 2019, 576 (7785) :149-+
[2]   The complement system in age-related macular degeneration [J].
Armento, Angela ;
Ueffing, Marius ;
Clark, Simon J. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2021, 78 (10) :4487-4505
[3]   Sucess in sight: The eyes have it! Ocular gene therapy trials for LCA look promising [J].
Bainbridge, J. W. ;
Ali, R. R. .
GENE THERAPY, 2008, 15 (17) :1191-1192
[4]   Long-Term Effect of Gene Therapy on Leber's Congenital Amaurosis [J].
Bainbridge, J. W. B. ;
Mehat, M. S. ;
Sundaram, V. ;
Robbie, S. J. ;
Barker, S. E. ;
Ripamonti, C. ;
Georgiadis, A. ;
Mowat, F. M. ;
Beattie, S. G. ;
Gardner, P. J. ;
Feathers, K. L. ;
Luong, V. A. ;
Yzer, S. ;
Balaggan, K. ;
Viswanathan, A. ;
de Ravel, T. J. L. ;
Casteels, I. ;
Holder, G. E. ;
Tyler, N. ;
Fitzke, F. W. ;
Weleber, R. G. ;
Nardini, M. ;
Moore, A. T. ;
Thompson, D. A. ;
Petersen-Jones, S. M. ;
Michaelides, M. ;
van den Born, L. I. ;
Stockman, A. ;
Smith, A. J. ;
Rubin, G. ;
Ali, R. R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (20) :1887-1897
[5]   In Vivo CRISPR/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa [J].
Bakondi, Benjamin ;
Lv, Wenjian ;
Lui, Bin ;
Jones, Melissa K. ;
Tsai, Yuchun ;
Kim, Kevin J. ;
Levy, Rachelle ;
Akhtar, Aslam Abbasi ;
Breunig, Joshua J. ;
Svendseni, Clive N. ;
Wang, Shaomei .
MOLECULAR THERAPY, 2016, 24 (03) :556-563
[6]   CRISPR provides acquired resistance against viruses in prokaryotes [J].
Barrangou, Rodolphe ;
Fremaux, Christophe ;
Deveau, Helene ;
Richards, Melissa ;
Boyaval, Patrick ;
Moineau, Sylvain ;
Romero, Dennis A. ;
Horvath, Philippe .
SCIENCE, 2007, 315 (5819) :1709-1712
[7]   Highly Efficient Targeted Mutagenesis of Drosophila with the CRISPR/Cas9 System [J].
Bassett, Andrew R. ;
Tibbit, Charlotte ;
Ponting, Chris P. ;
Liu, Ji-Long .
CELL REPORTS, 2013, 4 (01) :220-228
[8]   Precision Medicine: Genetic Repair of Retinitis Pigmentosa in Patient-Derived Stem Cells [J].
Bassuk, Alexander G. ;
Zheng, Andrew ;
Li, Yao ;
Tsang, Stephen H. ;
Mahajan, Vinit B. .
SCIENTIFIC REPORTS, 2016, 6
[9]   Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward [J].
Bennett, Jean .
MOLECULAR THERAPY, 2017, 25 (05) :1076-1094
[10]   Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin [J].
Bolotin, A ;
Ouinquis, B ;
Sorokin, A ;
Ehrlich, SD .
MICROBIOLOGY-SGM, 2005, 151 :2551-2561